A single dose of tranexamic acid reduces blood loss after reverse and anatomic shoulder arthroplasty: a randomized controlled trial

Cunningham, Gregory; Hughes, Jeffery; Borner, Benoît; Mattern, Owen; Taha, Mohy E; Smith, Margaret M; Young, Allan A; Cass, Benjamin

doi:10.1016/j.jse.2020.11.022

Scientific article

Open access

English

A single dose of tranexamic acid reduces blood loss after reverse and anatomic shoulder arthroplasty: a randomized controlled trial

ContributorsCunningham, Gregory; Hughes, Jeffery; Borner, Benoît; Mattern, Owen; Taha, Mohy E; Smith, Margaret M; Young, Allan A; Cass, Benjamin

Published inJournal of Shoulder and Elbow Surgery, vol. 30, no. 7, p. 1553-1560

Publication date2021

Abstract

Hematoma formation and the need for blood transfusions are commonly reported complications after shoulder arthroplasty. Tranexamic acid (TXA) has been widely used in hip and knee arthroplasty to decrease perioperative blood loss. The role of TXA is still being established in shoulder arthroplasty.

Keywords

Antifibrinolytic Agents
Arthroplasty, Replacement, Shoulder/adverse effects
Blood Loss, Surgical/prevention & control
Blood Transfusion
Humans
Tranexamic Acid

Affiliation

Faculté de médecine / Section de médecine clinique / Département de chirurgie

Citation (ISO format)

CUNNINGHAM, Gregory et al. A single dose of tranexamic acid reduces blood loss after reverse and anatomic shoulder arthroplasty: a randomized controlled trial. In: Journal of Shoulder and Elbow Surgery, 2021, vol. 30, n° 7, p. 1553–1560. doi: 10.1016/j.jse.2020.11.022